Women's Cardiovascular Health After a Hypertensive Disorder of Pregnancy
Authors: Abigail Fraser
Journal: Annals of Internal Medicine (2018)

Editorials21 August 2018Women's Cardiovascular Health After a Hypertensive Disorder of PregnancyAbigail Fraser, BA, MA, MPH, PhDAbigail Fraser, BA, MA, MPH, PhDBristol Medical School, University of Bristol, Bristol, United Kingdom (A.F.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/M18-1443 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail More than a quarter of parous women experience a complication during pregnancy, such as a hypertensive disorders of pregnancy (HDP) (preeclampsia or gestational hypertension), gestational diabetes, fetal growth restriction, or preterm delivery. Substantial evidence shows that these women are approximately twice as likely as those with uncomplicated pregnancies to later develop cardiovascular disease (CVD) (1).Using data from NHS II (Nurses' Health Study II), Stuart and colleagues report associations between a history of a first pregnancy complicated by an HDP and physician-diagnosed hypertension, hypercholesterolemia, and type 2 diabetes over the course of 3 decades after pregnancy (2). They found that ...References1. Rich-Edwards JW, Fraser A, Lawlor DA, Catov JM. Pregnancy characteristics and women's future cardiovascular health: an underused opportunity to improve women's health? Epidemiol Rev. 2014;36:57-70. [PMID: 24025350] doi:10.1093/epirev/mxt006 CrossrefMedlineGoogle Scholar2. Stuart JJ, Tanz LJ, Missmer SA, Rimm EB, Spiegelman D, James-Todd TM, et al. Hypertensive disorders of pregnancy and maternal cardiovascular disease risk factor development. An observational cohort study. Ann Intern Med. 2018;169:224-32. doi:10.7326/M17-2740 LinkGoogle Scholar3. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al; ESC Scientific Document Group. 2016 European guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37:2315-81. [PMID: 27222591] doi:10.1093/eurheartj/ehw106 CrossrefMedlineGoogle Scholar4. Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update: a guideline from the American Heart Association. Circulation. 2011;123:1243-62. [PMID: 21325087] doi:10.1161/CIR.0b013e31820faaf8 CrossrefMedlineGoogle Scholar5. Brown HL, Warner JJ, Gianos E, Gulati M, Hill AJ, Hollier LM, et al; American Heart Association and the American College of Obstetricians and Gynecologists. Promoting risk identification and reduction of cardiovascular disease in women through collaboration with obstetricians and gynecologists: a presidential advisory from the American Heart Association and the American College of Obstetricians and Gynecologists. Circulation. 2018. [PMID: 29748185] doi:10.1161/CIR.0000000000000582 CrossrefMedlineGoogle Scholar6. GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1151-210. [PMID: 28919116] doi:10.1016/S0140-6736(17)32152-9 CrossrefMedlineGoogle Scholar7. Frejka T. Childlessness in the United States. In: Kreyenfeld M, Konietzka D, eds. Childlessness in Europe: Contexts, Causes, and Consequences. Cham, Switzerland: Springer International Publishing; 2017:159-79. Google Scholar Author, Article, and Disclosure InformationAffiliations: Bristol Medical School, University of Bristol, Bristol, United Kingdom (A.F.)Financial Support: Dr. Fraser is supported by a U.K. Medical Research Council fellowship (MR/M009351/1) and works in a unit that is supported by the U.K. Medical Research Council and the University of Bristol (MC_UU_12013/5).Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M18-1443.Corresponding Author: Abigail Fraser, BA, MA, MPH, PhD, Population Health Sciences, Bristol Medical School and the MRC Integrative Epidemiology Unit at the University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, United Kingdom; e-mail, Abigail.[email protected]ac.uk.This article was published at Annals.org on 3 July 2018. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoHypertensive Disorders of Pregnancy and Maternal Cardiovascular Disease Risk Factor Development Jennifer J. Stuart , Lauren J. Tanz , Stacey A. Missmer , Eric B. Rimm , Donna Spiegelman , Tamarra M. James-Todd , and Janet W. Rich-Edwards Metrics 21 August 2018Volume 169, Issue 4Page: 258-259KeywordsCardiovascular diseasesDisclosureHealth information technologyHypertensionMaternal healthMedical risk factorsPreeclampsiaPregnancyPregnancy complicationsType 2 diabetes ePublished: 3 July 2018 Issue Published: 21 August 2018 Copyright & PermissionsCopyright © 2018 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...